Biotechnology Assets, S.A. (BME:BST)

Spain · Delayed Price · Currency is EUR

0.2250

0.00 (0.00%)

Sep 16, 2026, 5:35 PM CET

Market Cap	16.71M -37.0%
Revenue (ttm)	3.43M -4.9%
Net Income	-1.92M
EPS	n/a
Shares Out	74.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,500
Open	0.2130
Previous Close	0.2250
Day's Range	0.2130 - 0.2250
52-Week Range	0.1760 - 0.4310
Beta	1.82
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 21, 2026

About Biotechnology Assets

Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a solution for site-specific conjugation of proteins; Click Car for Split-CARs universal connectors; VACC-ZERA, a tool to generate recombinant proteins in microparticles; and CLICK’N CUT for tag-less protein purification. The company is based in Cádiz, Spain. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1954

Employees 26

Stock Exchange Madrid Stock Exchange

Ticker Symbol BST

Full Company Profile

Financial Performance

In 2025, Biotechnology Assets's revenue was 3.43 million, a decrease of -4.88% compared to the previous year's 3.61 million. Losses were -1.92 million, -34.32% less than in 2024.

Financial Statements